EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neuronal surface and intracellular antibody testing in patients with long‐term epilepsy

Nancy Watanabe iD, Angelica Lizcano iD, Tânia K de Araujo, Renata Barbosa, Marina K M Alvim, Andre S Vieira iD, Iscia Lopes-Cendes iD, Fabio Rogerio iD, Clarissa L Yasuda iD, Fernando Cendes iD

Epilepsia Open · 2025

DOI: 10.1002/epi4.70096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia Open, 2025. Verfasst von Nancy Watanabe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Campinas (UNICAMP), Campinas, SP, Brazil. Hauptthemen laut MEDLINE: Autoantibodies, Epilepsy, Neurons, Epilepsy, Temporal Lobe. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

We aimed to investigate the frequency of neuronal surface and intracellular antibodies in individuals with long‐term epilepsy and the associated clinical and laboratory characteristics.

Methods

We tested sera from 223 patients with epilepsy without signs of autoimmune encephalitis and 12 patients with epilepsy and a subacute onset of additional neurological symptoms. All had epilepsy lasting at least one year. We compared clinical and laboratory characteristics between those with and without antibodies. Additionally, we assessed the ACES and APE scores, and ONES checklist for identifying patients with antibodies.

Results

Only one of 223 patients with epilepsy and no autoimmune encephalitis signs (0.4%) had antibodies, presenting with drug‐resistant mesial temporal lobe epilepsy and hippocampal sclerosis (MTLE‐HS) and GAD antibodies. She had no improvement after surgical treatment (Engel IV). Of the 12 patients with subacute onset of additional neurological symptoms, four (33.3%) had antibodies: two anti‐GAD, one anti‐LGI1, and one anti‐Hu. Antibody‐positive patients showed later epilepsy onset, had more seizure frequency fluctuations, cutaneous drug reactions, and electrographic seizures compared to antibody‐negative patients. All of them had TLE, and anti‐GAD cases had refractory unilateral MTLE‐HS, musicogenic seizures, and temporal hypermetabolism on interictal FDG‐PET. The ONES checklist had the highest sensitivity and specificity to identify patients with antibodies. Significance All patients with long‐term epilepsy and neuronal antibodies had TLE, with 60% exhibiting MTLE‐HS associated with GAD antibodies. Neuronal antibodies were rarely detected (0.4%) among patients with isolated long‐term epilepsy, but when present, they were associated with specific clinical and laboratory features. Plain Language Summary Neuronal antibodies are biological markers of autoimmune encephalitis, a condition that causes sudden and rapidly worsening cognitive decline, changes in mental state, and psychiatric symptoms, often accompanied by seizures and other neurological issues. In our study, we investigated how often these antibodies appear in patients with isolated long‐term epilepsy and what clinical or laboratory characteristics are associated with them. We found neuronal antibodies only in patients with temporal lobe epilepsy. These antibodies were rare (0.4%) among patients with long‐term epilepsy alone and were linked to specific clinical and laboratory features.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutoantibodiesEpilepsyNeuronsEpilepsy, Temporal LobeHumansFemaleMaleAdultMiddle AgedYoung AdultAdolescentDrug Resistant EpilepsyGlutamate DecarboxylaseHippocampus

Stichwörter der Autor:innen

anti‐GADautoimmune‐associated epilepsyneuronal antibodiestemporal lobe epilepsy

Substanzen

AutoantibodiesGlutamate Decarboxylase

Autor:innen und Institutionen

  • Department of Neurology, University of Campinas (UNICAMP), Campinas, SP, Brazil.
  • Department of Translational Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil.
  • Department of Structural and Functional Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, SP, Brazil.
  • Department of Pathology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil.

ORCID-Profile: Nancy Watanabe, Angelica Lizcano, Andre S Vieira, Iscia Lopes-Cendes, Fabio Rogerio, Clarissa L Yasuda, Fernando Cendes

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Watanabe, N., Lizcano, A., de Araujo, T. K., Barbosa, R., Alvim, M. K. M., Vieira, A. S., Lopes-Cendes, I., Rogerio, F., Yasuda, C. L., & Cendes, F. (2025). Neuronal surface and intracellular antibody testing in patients with long‐term epilepsy. Epilepsia Open. https://doi.org/10.1002/epi4.70096

Vancouver

Watanabe N, Lizcano A, de Araujo TK, Barbosa R, Alvim MKM, Vieira AS, et al. Neuronal surface and intracellular antibody testing in patients with long‐term epilepsy. Epilepsia Open. 2025. doi:10.1002/epi4.70096

BibTeX
@article{Watanabe2025,
  author = {Watanabe, Nancy and Lizcano, Angelica and de Araujo, Tânia K and Barbosa, Renata and Alvim, Marina K M and Vieira, Andre S and Lopes-Cendes, Iscia and Rogerio, Fabio and Yasuda, Clarissa L and Cendes, Fernando},
  title = {Neuronal surface and intracellular antibody testing in patients with long‐term epilepsy},
  journal = {Epilepsia Open},
  year = {2025},
  doi = {10.1002/epi4.70096}
}
Kostenlos starten →